Cordis Global Medical Technology

ETL4642AU

Cordis Global Medical Technology ETL4642AU Strategy

The Fund follows a fundamental long-only active strategy. Cordis runs a high conviction actively managed specialised portfolio, limited to between 20-40 stocks selected from the medical technology sub-sector of listed global healthcare companies.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.

Funds News & Analysis

funds

Chart of the week: A reliable predictor of the success of an investment

This week's chart of the week looks at the impact of fees on the success of funds.
funds

Listed Investment Companies monthly performance: October 2024

The Morningstar LIC monthly report provides a snapshot of ASX-listed LICs, and whether they are trading at a premium or a discount to their net tangible assets (NTA).
funds

How to tell if a fund or ETF will likely underperform

The funds that have been rated negative by our analysts have characteristics in common.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,550.3036.60-0.43%
CAC 407,409.5711.37-0.15%
DAX 4020,405.9220.35-0.10%
Dow JONES (US)43,828.0686.06-0.20%
FTSE 1008,300.3311.43-0.14%
HKSE19,971.24425.81-2.09%
NASDAQ19,926.7223.880.12%
Nikkei 22539,470.44378.70-0.95%
NZX 50 Index12,754.2661.540.48%
S&P 5006,051.090.16-0.00%
S&P/ASX 2008,296.0034.30-0.41%
SSE Composite Index3,391.8869.62-2.01%

Market Movers